Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation: a Placebo-controlled, Double-blinded Randomized Controlled Trial

NCT03136068 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03136068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03136068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation: a Placebo-controlled, Double-blinded Randomized Controlled Trial
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
February 23, 2017
Completion date
May 31, 2018
Enrollment
178 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

abortion